Table 3.

The 1-year incidence (%, 95% CI) of cancers in participants aged 60–69 years with abdominal pain plus another feature of possible cancer, stratified by sexa

Additional feature and cancerWomenMen
1-year incidence (%)95% CI1-year incidence (%)95% CI
Colorectal or pancreatic2.7c1.6 to 4.4c4.0d2.6 to 6.0d
Colorectal1.7b0.8 to 3.1b1.2b0.5 to 2.5b
Pancreatic1.0b0.4 to 2.2b2.8c1.6 to 4.5c
Colorectal or pancreatic1.5b0.7 to 2.8b3.1d1.9 to 4.9d
Colorectal1.1b0.4 to 2.2b2.2c1.2 to 3.8c
Pancreatic0.50.1 to to 2.0
Change in bowel habit
Colorectal or ovarian3c1 to 6cn/aen/a
Colorectal2c1 to 6c
Ovarian0.50.1 to 2.7n/an/a
Nausea and/or vomiting
Pancreatic or oesophagogastric1.4b0.6 to 2.8b4d2 to 7d
Pancreatic1.2b0.5 to 2.5b3.1d1.5 to 5.6d
Oesophagogastric0.20.1 to to 2.7
Abdominal mass
Colorectal, ovarian, oesophagogastric, or liver10d3 to 21d9d2 to 25d
Colorectal6d1 to 16d3d0 to16d
Oesophagogastric0n/a3d0 to 16d
Ovarian2c0 to 10cn/a
Liver2c0 to 10c3d0 to 16d
Weight loss
Colorectal, ovarian, pancreatic, or oesophagogastric5d2 to 12d9d5 to 16d
Colorectal2c0 to 8c2c0 to 6c
Oesophagogastric0n/a2c0 to 6c
Pancreatic3d1 to 9d6d2 to 12d
  • a For each feature, the total risk and that of contributing cancers is reported. Estimates are reported to the precision afforded by the standard errors, which varies with the cancer–feature combination.

  • b Cancer risk1% and <2%.

  • c Cancer risk2% and <3%.

  • d Cancer risk3%.

  • e There are no data for men for change in bowel habit, as the composite outcome is not meaningful for male sex, who are not diagnosed with ovarian cancer. CI = confidence interval. n/a = not applicable.